{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2022-10701:v1","objectPathId":"federal-register-2022-10701-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2022-10701/","json":"https://peptidescanner.com/evidence/v1/objects/federal-register-2022-10701-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/federal-register-2022-10701-v1.md"},"story":{"slug":"federal-register-2022-10701","version":1,"domain":"Regulatory","dateInSource":"2022-05-20","sourceCheckedAt":"2026-08-21","publishedAt":"2026-08-21","peptideSlugs":["exenatide","linaclotide"],"peptides":[{"slug":"exenatide","url":"https://peptidescanner.com/peptides/exenatide/"},{"slug":"linaclotide","url":"https://peptidescanner.com/peptides/linaclotide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2022-10701","sourceIds":["federal-register-2022-10701-62e4a0d275fa"]},{"id":"summary","text":"The Federal Register published notice 2022-10701, attributed to FDA and its parent HHS department, on 2022-05-20. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide and Linaclotide.","sourceIds":["federal-register-2022-10701-62e4a0d275fa"]},{"id":"paragraph-1","text":"The Federal Register published notice 2022-10701, attributed to FDA and its parent HHS department, on 2022-05-20. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide and Linaclotide.","sourceIds":["federal-register-2022-10701-62e4a0d275fa"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2022-10701-62e4a0d275fa"]}],"sources":[{"id":"federal-register-2022-10701-62e4a0d275fa","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2022-10701 · published 2022-05-20 · Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability","url":"https://www.govinfo.gov/content/pkg/FR-2022-05-20/pdf/2022-10701.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"49063e03d71d5bb4355c5529b149892bb08d669d215848281ba4fa19e2e6e293","tierARecordSha256":"62e4a0d275fadaa4fdb12a322cbc5712576155e302204599104c3db9bfb4dc08"},"integrity":{"algorithm":"sha256","contentSha256":"7a4a668c3a3c641da517ad35f2c99d14feffa0ed678f34fd102d2be470af1b7f"}}